What is Inotersen: Uses, Dosage, Side Effects and More

Inotersen is a prescription medication specifically designed to treat hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), a rare genetic condition that affects your nerves and organs. This medication works by reducing the production of a problematic protein called transthyretin, which can build up in your body and cause serious complications.

If you or someone you care about has been diagnosed with hATTR amyloidosis, you're likely feeling overwhelmed by all the medical information. Let's walk through what you need to know about this medication in simple, clear terms.

What is Inotersen?

Inotersen is an antisense oligonucleotide medication that you inject under your skin once a week. It belongs to a newer class of medicines that work at the genetic level to reduce disease progression.

This medication specifically targets the RNA instructions that tell your liver to make transthyretin protein. By blocking these instructions, inotersen helps reduce the amount of abnormal protein your body produces. Think of it as intercepting faulty messages before they can cause more damage.

The drug is given as a subcutaneous injection, which means it goes into the fatty tissue just under your skin. This allows the medication to enter your bloodstream gradually and work throughout your body.

What is Inotersen Used For?

Inotersen treats hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adults. This rare genetic condition happens when your body produces abnormal transthyretin proteins that clump together and damage your nerves and organs.

The condition primarily affects your peripheral nerves, causing symptoms like numbness, tingling, pain, and weakness in your hands and feet. Over time, it can also affect your heart, kidneys, and digestive system. Without treatment, hATTR amyloidosis typically gets worse and can become life-threatening.

Your doctor will only prescribe inotersen if you have a confirmed genetic diagnosis of hATTR amyloidosis. The medication is specifically designed for this condition and won't help with other types of nerve problems or amyloidosis.

How Does Inotersen Work?

Inotersen works by using your body's natural cellular machinery to reduce the production of transthyretin protein. It's considered a moderately strong medication that can significantly slow disease progression when used properly.

The medication targets the messenger RNA (mRNA) that carries instructions from your genes to your protein-making machinery. By binding to this mRNA, inotersen prevents your liver from making as much transthyretin protein. This reduces the amount of abnormal protein available to form harmful deposits in your body.

Studies show that inotersen can reduce transthyretin production by about 75-80% in most patients. This substantial reduction helps slow nerve damage and can stabilize or even improve some symptoms. However, it takes several months of consistent treatment to see meaningful benefits.

How Should I Take Inotersen?

You'll inject inotersen once a week on the same day each week, rotating between different injection sites. The medication comes in pre-filled syringes that you store in your refrigerator until use.

Before your injection, let the medication warm to room temperature for about 30 minutes. Clean your injection site with an alcohol swab and inject the medication into the fatty tissue of your thigh, upper arm, or abdomen. Your healthcare team will teach you the proper injection technique and sites to rotate between.

You can take inotersen with or without food since it's injected rather than taken by mouth. However, staying well-hydrated and maintaining good nutrition can help your body handle the medication better. Some people find it helpful to inject at the same time each week to establish a routine.

How Long Should I Take Inotersen For?

Inotersen is typically a long-term treatment that you'll continue indefinitely as long as it's helping and you're tolerating it well. Since hATTR amyloidosis is a progressive genetic condition, stopping the medication usually allows the disease to advance again.

Your doctor will monitor your response to treatment through regular blood tests and neurological examinations. Most people start seeing stabilization of their symptoms within 6-12 months, though some improvements may take longer to become apparent.

The decision to continue or stop inotersen depends on several factors including how well it's working, what side effects you're experiencing, and your overall health status. Your medical team will work with you to determine the best long-term plan for your specific situation.

What Are the Side Effects of Inotersen?

Like all medications, inotersen can cause side effects, though not everyone experiences them. The most common side effects are generally manageable with proper monitoring and care.

Here are the side effects you might experience, starting with the most common ones:

• Injection site reactions like redness, swelling, or pain
• Nausea and vomiting
• Headache
• Fatigue
• Fever
• Muscle aches
• Chills

These common side effects often improve as your body adjusts to the medication over the first few weeks of treatment.

More serious side effects require immediate medical attention and include:

• Severe reduction in platelets (thrombocytopenia) causing easy bruising or bleeding
• Kidney problems including glomerulonephritis
• Severe injection site reactions with significant swelling or infection
• Signs of inflammatory conditions

Your doctor will monitor you closely with regular blood tests to catch any serious side effects early. Most people can continue treatment safely with proper monitoring and dose adjustments when needed.

Who Should Not Take Inotersen?

Certain people should not take inotersen due to increased risk of serious complications. Your doctor will carefully evaluate whether this medication is safe for you before prescribing it.

You should not take inotersen if you have:

• Severe kidney disease or are on dialysis
• Active, uncontrolled bleeding disorders
• Severely low platelet counts
• Active infections that your immune system cannot control
• Known allergies to inotersen or its components

Special caution is needed if you have mild to moderate kidney problems, a history of bleeding disorders, or are taking blood-thinning medications. Your doctor may still prescribe inotersen but will monitor you more closely and possibly adjust your treatment plan.

Pregnancy and breastfeeding require special consideration, as the effects of inotersen on developing babies are not fully known. Your doctor will discuss the potential risks and benefits if you're planning to become pregnant or are already pregnant.

Inotersen Brand Names

Inotersen is sold under the brand name Tegsedi in most countries where it's available. This is the only brand name currently approved for this medication.

Tegsedi is manufactured by Akcea Therapeutics and is available in several countries including the United States, Canada, and many European nations. The medication comes in pre-filled syringes containing 284 mg of inotersen sodium.

Since this is a specialty medication for a rare condition, it's only available through specific pharmacies and requires prior authorization from your insurance company. Your healthcare team will help coordinate access to the medication through appropriate channels.

Inotersen Alternatives

Several other medications can treat hATTR amyloidosis, though each works differently and may be better suited for different patients. Your doctor will help determine which option is best for your specific situation.

The main alternatives include:

• Patisiran (Onpattro) - another RNA-targeting medication given by IV infusion
• Tafamidis (Vyndaqel) - a medication that stabilizes transthyretin protein
• Diflunisal - an older medication that can also stabilize the protein

Each alternative has different benefits and side effect profiles. Patisiran works similarly to inotersen but requires monthly IV infusions instead of weekly injections. Tafamidis works by preventing the transthyretin protein from unfolding and forming harmful deposits.

The choice between these medications depends on factors like your disease stage, other health conditions, ability to tolerate injections or infusions, and your personal preferences. Some people may need to try different options to find what works best for them.

Is Inotersen Better Than Patisiran?

Both inotersen and patisiran are effective treatments for hATTR amyloidosis, but they have different advantages and disadvantages. Neither is definitively "better" than the other – the best choice depends on your individual circumstances.

Inotersen offers the convenience of weekly self-injections at home, which many people prefer over monthly trips to an infusion center for patisiran. However, inotersen requires more frequent monitoring for side effects, particularly kidney and platelet problems.

Patisiran may have a slightly better side effect profile in some studies, but it requires monthly IV infusions that take several hours. This can be challenging for people who live far from infusion centers or have difficulty with IV access.

Both medications effectively reduce transthyretin production by similar amounts and can slow disease progression. Your doctor will consider factors like your lifestyle, other health conditions, and personal preferences when helping you choose between these options.